when do compounding pharmacies have to stop semaglutide Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Compounding Pharmacy Semaglutide: Deep Dive

That said, it's worth knowing the difference between typical irritation and something that needs prompt attention

FDA-approved weight loss medications are generally prescribed for those with a BMI of 30 or higher, or 27 and above if accompanied by a weight-related medical condition

Direct answer: Many patients successfully switch from semaglutide to tirzepatide when providers guide the process carefully and personalize treatment

For comprehensive storage guidance that applies to all peptide formulations, our peptide storage guide covers temperature requirements, light exposure considerations, and signs of degradation to watch for

10 By the end of 2026, AI will no longer be seen primarily as a pilot, and hospitals and payers will expect a positive return on investment (ROI) for AI applications